111 related articles for article (PubMed ID: 7883225)
1. Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.
Spigelman AD; Farmer KC; Oliver S; Nugent KP; Bennett PN; Notarianni LJ; Dobrocky P; Phillips RK
Gut; 1995 Feb; 36(2):251-4. PubMed ID: 7883225
[TBL] [Abstract][Full Text] [Related]
2. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
Rasmussen BB; Brøsen K
Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764
[TBL] [Abstract][Full Text] [Related]
3. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
4. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.
Relling MV; Lin JS; Ayers GD; Evans WE
Clin Pharmacol Ther; 1992 Dec; 52(6):643-58. PubMed ID: 1458773
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping.
Kashuba AD; Bertino JS; Kearns GL; Leeder JS; James AW; Gotschall R; Nafziger AN
Clin Pharmacol Ther; 1998 May; 63(5):540-51. PubMed ID: 9630827
[TBL] [Abstract][Full Text] [Related]
6. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
McQuilkin SH; Nierenberg DW; Bresnick E
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
[TBL] [Abstract][Full Text] [Related]
7. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine.
Vistisen K; Poulsen HE; Loft S
Carcinogenesis; 1992 Sep; 13(9):1561-8. PubMed ID: 1394840
[TBL] [Abstract][Full Text] [Related]
8. Caffeine metabolism in cystic fibrosis: enhanced xanthine oxidase activity.
Hamelin BA; Xu K; Vallé F; Manseau L; Richer M; LeBel M
Clin Pharmacol Ther; 1994 Nov; 56(5):521-9. PubMed ID: 7955816
[TBL] [Abstract][Full Text] [Related]
9. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
Tsutsumi K; Kotegawa T; Matsuki S; Tanaka Y; Ishii Y; Kodama Y; Kuranari M; Miyakawa I; Nakano S
Clin Pharmacol Ther; 2001 Aug; 70(2):121-5. PubMed ID: 11503005
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase Mu phenotype in patients with familial adenomatous polyposis and in unaffected controls.
Spigelman AD; Nugent KP; Penna C; Foulds S; Phillips RK
Cancer Detect Prev; 1994; 18(4):253-8. PubMed ID: 7982235
[TBL] [Abstract][Full Text] [Related]
11. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
[TBL] [Abstract][Full Text] [Related]
12. Low CYP1A2 activity in rural Shona children of Zimbabwe.
Masimirembwa CM; Beke M; Hasler JA; Tang BK; Kalow W
Clin Pharmacol Ther; 1995 Jan; 57(1):25-31. PubMed ID: 7828378
[TBL] [Abstract][Full Text] [Related]
13. Biliary bile acid profiles in patients with familial adenomatous polyposis before and after colectomy.
Barker GM; Radley S; Bain I; Davis A; Lawson AM; Keighley MR; Neoptolemos JP
Br J Surg; 1994 Mar; 81(3):441-4. PubMed ID: 8173925
[TBL] [Abstract][Full Text] [Related]
14. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.
Bertilsson L; Carrillo JA; Dahl ML; Llerena A; Alm C; Bondesson U; Lindström L; Rodriguez de la Rubia I; Ramos S; Benitez J
Br J Clin Pharmacol; 1994 Nov; 38(5):471-3. PubMed ID: 7893591
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
[TBL] [Abstract][Full Text] [Related]
16. Phenotype of cytochrome P450 CYP2D6 in patients with familial adenomatous polyposis.
Slanar O; Perlík F; Jirásek V
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):145-7. PubMed ID: 11523314
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK
Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922
[TBL] [Abstract][Full Text] [Related]
18. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism.
Chung WG; Kang JH; Park CS; Cho MH; Cha YN
Clin Pharmacol Ther; 2000 Mar; 67(3):258-66. PubMed ID: 10741629
[TBL] [Abstract][Full Text] [Related]
19. Does early colectomy increase desmoid risk in familial adenomatous polyposis?
Durno C; Monga N; Bapat B; Berk T; Cohen Z; Gallinger S
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1190-4. PubMed ID: 17916546
[TBL] [Abstract][Full Text] [Related]
20. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.
Lang NP; Butler MA; Massengill J; Lawson M; Stotts RC; Hauer-Jensen M; Kadlubar FF
Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):675-82. PubMed ID: 7881341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]